Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Mind & Matter

Mind & Matter artwork

SSRIs Can Cause Sexual Dysfunction That Lasts Years After Stopping | David Healy | 232

Jun 5, 20252 hr 10 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Send us Fan Mail A critique of SSRIs and pharma’s influence on medicine, including SSRI-induced sexual dysfunction, suicidality, and violence. Long Summary: Dr. David Healy critiques modern medicine, focusing on SSRIs and psychiatric medicine, including: how pharmaceutical companies manipulate clinical trial data, ghostwrite studies, and influence medical practice, often ignoring patient experiences; highlighting issues like post-SSRI sexual dysfunction (PSSD), the immediate sensory effects of SSRIs, and their potential to induce suicidal or violent behavior; challenging the reliance on randomized controlled trials (RCTs) over individual patient reports; and more. About the guest: David Healy, MD, PhD, a psychiatrist and pharmacologist, has decades of experience researching the serotonin system and SSRIs, working across Ireland, the UK, Canada, and the US. He is a professor at McMaster University and a vocal critic of pharmaceutical industry practices. Discussion Points: SSRIs cause near-immediate sensory effects, like genital numbing, in most people. Post-SSRI sexual dysfunction (PSSD) can persist for years or decades after stopping the drug, affecting many long-term users. Healy argues RCTs prioritize averages over individual experiences, often missing serious side effects like suicidality. Pharmaceutical companies ghostwrite studies and manipulate data, with journals like the New England Journal of Medicine publishing misleading articles. Serotonin theory of depression lacks evidence. Industry tactics include dismissing patient reports as anecdotes and using high doses in trials to mask weak efficacy. SSRIs can increase suicide risk, not just during initiation but also when adjusting doses or withdrawing, as seen in cases like the Aurora movie theater shooting. Regulatory bodies like the FDA often fail to investigate adverse effects due to bureaucratic processes and lack of follow-up. Healy emphasizes doctors’ failure to prioritize patient observations, driven by industry-influenced standards of care. Related episode: M&M 88: Depression, Serotonin, SSRIs, Psychiatry & Social Media | Joanna Moncrieff *Not medical advice. Support the show Support my work: Good Chemistry: Personalized, science-based health consulting. Work with Dr. Nick Jikomes directly. Affiliate Partners: Visit this link to see my affiliate partners and get discounts codes for products & services to support health. For all the ways you can support my efforts.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

Nick JikomesWhether food, drugs or ideas, what you consume, influences, who you become. On the mind and matter podcast, we learn together from the best scientists and thinkers alive today about how your mind body reacts to what you feed it before starting mind and matter, I spent 10 years in academia doing scientific research. I got a PhD in neuroscience, where I focused on neuro endocrinology and the neurobiology of behavior, and before that, I specialized in molecular developmental and evolutionary genetics. I used my scientific background to help parse and translate the information that guests share on the podcast. In addition to the podcast, I write long form written content inspired by the show, where I integrate what I've learned across episodes. I also have a free weekly newsletter where I provide you with upcoming guests, share links and provide commentary on scientific studies and research that I'm reading, and more, visit mind and matter.substack.com. To find all of my content.

Speaker 1You you very much for

David Healyjoining the day. It's good to be here. Nick, thanks for

Nick Jikomesasking me. And can you tell everyone a little bit about yourself? Where are you calling in from? And what's your background?

David HealyOkay, my background is that I've worked as a doctor for several decades at this point, and before I began that, I did some research on the serotonin system on which the SSRI group of drugs work. And that was very fortuitous in the sense that I was working on it before these drugs came on stream, and that meant that a range of people, like the companies that made SSRI drugs, that's the the selective serotonin reuptake inhibiting drugs used to treat people who are depressed or anxious, they figured I'd be a good person To educate other doctors and to the wider public on this group of drugs. Okay, so it meant I got to see what happened in the in as a lab with these drugs. It meant that I had links to most major pharmaceutical companies making these drugs. Were who kind of, it's a bit wrong to put like this, who thought I was one of them, and they talked reasonably openly and freely with me. I also got to see what happened when I gave the drugs to people, which isn't what the pharmaceutical companies were actually telling people was going to happen. So from that point of view, that's the background that's led to me being in this area. And over the course of the last 40 years or so, I've worked in Ireland and the UK and Canada, and I've been in the United States a lot, giving talks at various different universities and meetings, yeah,

Nick Jikomesyeah. And to be sure, we're going to talk a lot about, you know, SSRIs, pharmaceutical drugs, psychoactive drugs, Brain Stuff, psychiatry stuff, the things that probably most listeners are expecting, but also you're somewhat of a historian, and the place I want to start is actually sort of with the history of medicine and the history of Western civilization in general. And the place I want to start is with the story, or what you might call the myth, that that I once believed, which many people I think still believe, and that I was more or less taught, at least in indirect way in my education, which is what I'll just call one of the cartoon stories of Western civilization, which goes something like this. We had the religious Dark Ages, where we were ruled by priests and the church, and then we got enlightened. And after the enlightenment, we developed modern science and secular institutions. And then modern, secular technological progress took over, gradually ridding us of superstition, religious rituals and incantations and so forth and so today we have in medical practice and government policy, these things are determined in a secular, evidence based and scientific fashion. What's your basic critique of that version of Western history?

David HealyYeah, now that's an enormous question to ask up front and to kick us off, and I think there's a few flaws in it. One of the flaws is the religious approach towards things as. When you hear that word, you hear you think about people being holy, as it were. You think of them praying to God. You think of them on their knees and things like this. And that is one aspect to it, the mystic or the hermit or whatever, who goes off and just thinks about the things that count the other world. But in fact, one of the main functions of the religious enterprise is to keep the herd together. And in that sense, it's very tribal, yes, and in a sense, it also gave rise to the nation state, which is also all about keeping the herd together, right? And that works very well for ensuring that we've got the World Cup in football and the Olympic Games. You know, we need herds to compete at these things. And, you know, they can be fun, but keeping the herd together actually extends these days into science. Now maybe not so much physics, but certainly medicine, and certainly Mental Health Medicine where people are particularly tribal, you got people who say, well, we need to handle mental health problems by taking a psychotherapeutic approach, where you get other people saying, well, we need to use drugs to treat other problems, and you get a situation where the two tribes can barely talk to each other. And this is rather like the political situation in the United States at the moment, which has become much more tribal than it ever was before. So the idea that we've been moving from a dark ages to an enlightened period of time is all wrong. I think we seem to be as tribal as we ever were, and the job remains one of how to be enlightened, how to proceed in a way that's going to help others, rather than have us all confined to our particular boxes. And the SSRI story reveals how badly wrong a tribal approach can can be, and also reveals what the alternative might be one

Nick Jikomesof the, one of the possible analogies I want to explore here is when you look at the history of, say, Christianity in the West, you know, in highly simplified terms, you have the Catholic Church, who is sort of running things for a very long time, and then we have the Protestant Reformation, And a big component of this involved the technological innovation of the printing press, which allowed the Bible to be printed and literacy rates to eventually go up, and people could read the Bible themselves, instead of having to take a priest's word for it. In other words, the Bible was sort of made open access, and it was sort of hidden before and we had to rely on the priest class to tell us what was in it, and basically take their word for it. It was, you know, knowledge came by Fiat. And so the Protestant Reformation was very powerful because it had this sort of decentralizing, democratizing effect on access to information, in that case, in the Bible and had, you know, huge social consequences today. You know, we, I wonder if there's an analogy we can draw with the whole sort of scientific enterprise where, you know, we still sort of rely on a class of what we call experts to tell us what is in the sort of esoteric literature that the average person can't really discern. And right now, we do seem to be in a what you might analogize to a printing press. Democratization era of information in that a lot of the information that used to be hidden is now percolating throughout society. People have access to it via the Internet and other things. Is there a legitimate analogy to draw here? Is there an analogy to draw between sort of the literal priest cast, or class of the pre enlightenment era and the so called expert class of today? And that we often have to rely on them to simply tell us what they say. The literature says,

David Healyyeah. Now that's a great question and a great point to make, and I think there's a degree of truth to it, but also there's a degree of nuance that we need, which is, the internet comes on stream. Oh, I guess somewhere in the late 80s, early 90s, and by the end of the 1990s it's looking like it's going to be a great democratizing force. And it's particularly appreciated by people who are on the SSRI group of drugs and having problems from them. People are actually becoming suicidal, people who are getting hooked to drugs and finding if. Very hard to get off them. And when they go to the doctor, to the priestly cast, they're told, No, no, no, these things can't happen. We've got evidence based medicine, which is, you know, the Bible. It's the articles that appear in the New England Journal of Medicine, which is as close to the Bible as you can get these days, you know. And they're claiming that these drugs don't cause that problem. But, you know, the drugs only work. They don't have serious problems. Or if they do have problems, you know, they're awfully rare, but in actual fact, they're extremely common. And the internet appeared to be opening things up, and a bit like, as you said, the printing press. It was putting people in the kind of position where they could read things, they could find. Other people were having the same kind of experiences, the same kind of problems. Other people were being gaslit the way they were, too, and it looked like it was going to make a huge difference. So this was around 2004 2005 it really looked like the internet was changing things for the better. But what became clear around that time as well was industry realized this, yes, and industry realized that the internet was great way to sell drugs, and they needed to colonize the internet. And the internet, to a large extent, is completely run by industry these days. Yes, you can find groups that where people who are having problems on drugs meet and talk about the problems. But you also hear that on maybe Facebook groups for people who are on this antidepressant or that antidepressant, if they start talking about the antidepressant causing them to actually become suicidal or have kind of serious problems, they find that this is viewed as misinformation, and the group gets shut down. And that was probably most obvious during the COVID pandemic, the internet really looked like a force for social control, yes, rather than something that was liberating us to be able to work out what might be happening to us. Now, having said that, there's a change in the internet going on just at the moment, we now have a version of AI, and that really does more than let us search things. It really throws a lot of them, as opposed to us having to hunt for the information. It's throwing a lot of information at us. And in many respects, it does create the kind of situation where, if you're on a drug, and it isn't just the SSRI group drugs, is true for all drugs, and you go to your doctor having a problem on this drug, you can be armed with a huge amount of information without having to do too much hard work. You can know more about the drug that you're on than your doctor knows. So in a sense, it is creating a situation where there has to be a different kind of conversation. My worry is that we may be facing a moment that's a little bit like the 2004 moment. We thought we had the internet. We thought it was going to democratize things, but we've ended up being controlled by it? Yeah. AI has the possibility that it may open things up. Whether we're going to be able to seize the opportunity and really open things up or not is far less clear. Yeah, yeah.

Nick JikomesAnd of course, there's a lot of complicated dynamics that come with how these things unfold across history. So for example, if we go back to the printing press analogy and the Protestant Reformation, yes, the general, average effect of the printing press was that more books were published, more people had access to more things, on average. But then, of course, this prompts business development in the form of, say, publishing houses starting and they can take advantage of this to then sort of reconsolidate and re centralize and thereby control what does and doesn't get published and what does and does not get read. And then, of course, later on, today, self publishing is much more common now, so those publishing houses have less centralized control. And so these things sort of unfold and evolve in this sort of back and forth way over time. I think, as you're pointing out, on average, yes, the internet makes more information available to more people, on average. But, you know, we've seen over the past few years, in the last decade or so, you know, the way that social media platforms like Facebook can control and sensor information other platforms can do the same. And so, you know, there's this really rich dance that goes on between information democratization and decentralization, and then recentralization and control in new forms through new technologies. And you know, it's shaping information flow in complicated ways. But at the end of the day, sort of a common denominator here is that there's always going to be central special interests that want to centralize some. This, you know, information flow as best they can to serve their own purposes. And then, you know, there will be other forces that want to sort of decentralize it, to make it more widely available. And these things are always sort of in a kind of dance or competition with each other.

David HealyThat's a really good way to put it. But let me introduce a story about the SSRI group of drugs that may help give people a feel for the tips we're talking about and what it is we need to be aiming at. Okay, so way back when you opened up this line of thinking, you said we moved from the dark ages to a more enlightened period we had, you know, the scientific period. And we've got a lot of people who think about science and things like that. And within the mental health field, you had people like Freud and young and things like that, and it was very theory based. You weren't encouraged to test hypotheses to see what was going on, but it's very theory based now medicine, curiously, sheds an interesting light on that view of science, which is, if you go back and look at the history of medicine, it's fairly static, From the time the Greeks through to the American Civil War, roughly, and you had a bunch of young guys thrown into the civil war with no medical training really, facing the carnage that was going on on both sides, and developing modern surgery, how to fix injuries people hadn't seen before. Previously, you know, there have been swords and things like that, and people got stuck with swords or spears or maybe bayonets, but now they were being shot by bullets, and bones were being kind of fractured in ways that they hadn't been fractured before. And you'd a need to work out how to fix this, and with no theory telling you how to do it right. Very much, based on looking at what was happening to the person right in front of you, and trying to work out what seemed to work and finding things, one of the one of the things that was curious that had actually, actually happened just a short while before. That was we had the the discovery of ether and its use for anesthesia, and people could do surgical operations that they hadn't been able to before. They could remove legs in a way that could be done without too much trouble, too much pain and things to that. And in the Civil War, they also learned that, well, we need to do it hygienically and putting one thing the other, surgery took off. Now it's not theory based. It's based on doing the things that seem right in the moment, based on the observations, you know,

Nick Jikomeslike in front of using the evidence of your eyes and ears directly. Yeah.

David HealyAnd the other aspect to it, though, which is really touched on, is that, you know, the military realized quite quickly that actually the side was going to win the war. Was the one that was able to keep its soldiers alive up till then, and actually up till 1904 there, it had always been the case that in a war, more troops died from disease and injuries than died from enemy fire or enemy combat. The first country to have more people die from combat rather than illness, disease and things like that, was Japan fighting Russia in 1904 they beat the Russians, but also ended up with less troops dead. So that's been a thing that has stimulated a lot of action within the field of medicine, which up till 1945 or so was principally, was principally actually surgical and driven by the needs of the military more than anything else. Yeah, yeah, to an extent that's still the same. We've got kind of surgery been done by robots. We've got surgery been done at a distance, you know, because we need to be able to go into space. So we need to be able to operate on people who are hundreds of 1000s of miles away. And things of this and these are all military needs. Now, let me go back to. Around 1950 we begin to get the first drugs, not just mental health drugs, but across medicine. And they're rather like surgery. They're really not theory based. People had theories about illnesses and things of that and operating according to the theory you bled people or purged them, or things like this in like that kind of theory went out. That kind of theory actually went out the window. We began doing things with pills and observing what happened, okay, and in the case of the the SSRI group of drugs, and all the drugs we have in the the mental health field. First of all, you had a bunch of people who got Nobel prizes because we're new machines. We could give people drugs. So we could give the drugs, maybe to rats, things like that. And we had new machines which looked at plasma levels and brain levels and things of that. And the people won the Nobel Prize. Didn't win these prizes because they were actually awfully bright compared to the rest of us. They won the prizes because they were the first people who were able to observe new things. It was not theory driven. It was it was we ended up with a world that was being built from the ground up with the SSRI group of drugs, we had an older set of antidepressant drugs, which all looked, in theory, to be the same kind of thing. They were built on a on a a molecular core, where all the drugs looked pretty much they looked pretty much the same and that they should be doing much the same thing. But a man called Albert Carlson, looking at these and listening to patients, heard some of the patients saying, Well, this drug over here chills me out in a way that this one over there doesn't. And he was able to spot the fact, well, actually, the one that seemed that people seem to be saying, This chills them out. This also acts on the serotonin system in a way that the one on the opposite side actually doesn't do so why don't we try and make a drug that inhibits serotonin reuptake, but not nor epinephrine reuptake, and see what it looks like. Okay? And out of that we get the SSRI group drugs. Now I'm getting close to the key points here, which is Carlson thought there's nothing wrong with the serotonin system in people who are anxious or depressed or whatever. He thought, you have a group of drugs like LSD that act on a normal serotonin system, and are going to cause some people to say yes, that actually suits me and could be helpful, and other people say no, that really doesn't suit me and feels awful, you know? So this was not a view of pills as curing an illness, it was a view of pills as things that could do useful things for some people, but not others. And if you ask Carlson, could SSRI drugs cause people to become suicidal? And his answer was yes. And a few years later, he was faced with a group of people,

Nick Jikomeswhat time period are we in right now?

David HealyWell, he created the first SSRI in the late 1970s Okay, and one of the key points there is that people looking at this now say, well, it was very rational thing to do. It was very in a sense theory based. But no, it wasn't. It was based on looking at and listening to people and believing what people told them. Other people looking at the drugs we had beforehand, thought they must all be doing much the same thing, whereas he was listening to people and operating on what he heard from them, so he creates the first SSRIs. And if you ask them, ask them, look, could these drugs make people suicidal? The answer was yes, they could. And he was faced some years later, about, oh, the 1990s late 1990s with a group of people who had OCD and the SSRI group of drugs are great to treat OCD, but this group of these patients saying to him, Look, your drugs don't suit us. They aren't helping the OCD. They make us feel suicidal. We find it a lot better when we take nicotine. Now. So I'm not an advocate for nicotine, because my father died from lung cancer because he actually smoked too much, okay, so I'm not saying to people listening in that you must race out and get nicotine. Okay, but Carlson was looking at people and listening to them and said, Okay, well, let's run a trial of nicotine in OCD, in people who do poorly on SSRIs. And the outcome of the trial was, well, actually, yes, there's a very big group of people who have OCD, where the first line treatment is SSRIs, still, but actually nicotine does a lot. Can be much more helpful to a load of people who've got OCD than an SSRI. When

Nick Jikomesyou say helpful, what exactly is it helping? Is it helping control their compulsions so they don't repetitiously do things over and over again?

David HealyWell, it's more a case, I think, of the reason so many people ended up taking nicotine was not because it's very a addictive and you can't get off and it's easy to get off nicotine than get off an SSRI. It was, you know, people aren't totally crazy when it became clear that these that nicotine can kill you with kind of heart attacks, lung cancer, things that people got a load more cautious about it. But they also were taking nicotine because it makes you less anxious. It can calm a lot of people down and sorry

Nick Jikomesat this time when you say they were taking nicotine, was that in the form of small of smoked cigarettes? Yes,

David Healyyes, absolutely, yeah. But the point I'm trying to make here, and this is where people get awfully worked up if I say to a liberal audience, people who vote for left wing parties. People think we're making progress. We're moving into a world that's enlightened. If I say to them, Look, you know, the art of medicine is about bringing good out of the use of a poison, people hiss at me. They hold up the crucifix and garlic, saying, you know, we aren't. We aren't. We aren't actually prepared to listen to this guy. If I say that about nicotine, they say, oh, yeah, sure, yeah, it's a poison. You know, you'd be absolutely crazy to take it. But if you're a good doctor working with a person who has a problem, you can bring as much good as the use of nicotine or alcohol or maybe cannabis or whatever, as you can bring from an SSRI.

Nick JikomesAnd you're not saying you're not saying like, one's good and one's bad, one's holy and one's evil. You're saying they both have upsides and downsides, and they can be used as tools according to the patient's needs.

David HealyWell, the Yeah, yes. A little bit of what I'm saying is that we're all different. Yeah, okay, there were the people who thought Floyd was great, and the kinds of things he said worked for them. And lots of the people were, you know, more inclined to figure, well, actually, you know, the stuff we're hearing from Young is great, better than what we're hearing from Freud, and that line of thinking suits us. Loads of other people then think that CBT is useful for them. None of the I mean, I can see the appeal behind all of these three kind of therapies. None of them work for me. You know, you know, the point I'm making is that we're all different, and the key to me helping you, or you helping me, is to be able to listen and look and observe you do not want to be going to a doctor who is theory bound, who has a view about what the right answer is. The right answer for you are the one that's going to help you. Really involves me being able to look at you, listen to you, and possibly look at and listen to you over a period of time to see the changes that could have been if we introduce this drug or this therapy, if I can see changes in you over a period of days or weeks or whatever, that's the kind of thing that we need to build on, rather than adhering to the Bible are the New England Journal of Medicine, are the theory. Now, that's what medicine introduces into the way we think about things. There are ethical issues that go with it. You know, there are things about, Well, is it a good idea to be using nicotine to treat nervous problems, which are a bit like using ether. You know, you can do kind of surgery if we've got either that you can't do without it. But also there is a risk that using anesthesia to this day can kill you. So we're taking our risk on killing you. In order to try and to achieve a greater good. Yeah, yeah, but it's not theory bound. It's just it is a good idea to help you, if we can.

Nick JikomesYeah. I think one of the things worth exploring here is, you know what, what the nature of evidence is in the modern biomedical era? So, you know, it does. Does the word, the subjective report of a person count as legitimate evidence? You know? Some people might say, you know, some people, some people refer to what individuals say as anecdotes. That's not data. You know. To what extent should we count someone's word you know, rather than relying solely on the results of large trials where you're averaging lots of people together, and, you know, calculating p values and these things, you know, what do you do in a case where you know, a person say, gets prescribed a medication and they say it affects them in some strange way that deviates from what the average outcome is in the big Studies, you know, do you is that an anecdote, or do you count that as real data? I think probably different people have different opinions on how you should weight a person's personal subjective report.

David HealyYeah. Okay, and let me take you back to a man called Austin Bradford Hill, who was one who ran the first randomized control trial, the first RCT, and his view was, you should put more weight on the subjective report of the person that you're treating than on an RCT. RCTs give you averages. They don't tell you what to do for the person right in front of you, and your job, if you're trying to help the person right in front of you is to pay heed to them, and of course, they've got they're a privileged source of information on what's happening to them that you ignore at their peril and your own peril too. Well, I should change that a little bit if you're a pilot on a plane and I'm trying to get you from New York to the West Coast, and you spot something kind of wrong with the plane, you know, I'm going to pay heed to you, because if you're right, we're both going to die if we don't fix it in medicine. Of course, it isn't like that. If you're right and the drug is going to kill you, if I don't change things, if I pay no heat to you, you're going to die. But I'm not. So it's a different situation. So in New York, and that's a little bit of the problem we have at the moment, which is increasingly with what's called Evidence based medicine, which is we're going to go by the results of randomized control trials. People are being lost. The what's happening to the person right in front of a doctor gets lost. The doctors not paying heed, not looking at closely, not listening closely to not there's no no continuity of input either, which is sort of awfully helpful. You know, if I've seen you before, if I've seen you the week before, you actually went in these pills, and you come in to see me now, and I can spot the difference in you, either good or bad, that's crucial. I may actually, I mean, you know, I have to open the door to you've been able to let me know what's going on. Often, people have, they've been told that they have to take these drugs, the SSRI group of drugs, for weeks before they'll be sure that they're actually working or not. Carlson's view, and my view about these drugs, is, if they're not suiting you, within the first 24 hours, you should stop them. But people go on these drugs, they begin to think weird thoughts. They don't feel good. The them at the doctor these days is inclined to say, well, this is your illness getting worse. You know, you're actually more ill than I thought you were. Maybe we need to increase the dose of these pills, or maybe we need to add other pills in. Let me tell you two quick things on that school, I did a healthy volunteer trial with the access right group of drugs. When I say I did, I ran a healthy volunteer trial and a bunch of my, my, my, my, a bunch. We recruited a lot of the nursing staff and the medical staff in the unit in which I was working to the actual trial. And there was two different drugs that could be on, one of which was an SSRI and the other of which had no actions on the. Serotonin system at all, okay? And the idea with you the trial was to try and work out was Alfred Carlson, right? Was a drug that acts in the serotonin system going to chill people out in a way that a drug that's an antidepressant, which didn't act in the serotonin system wouldn't do and the answer is that he was right. But here's the interesting bit, as the patients in the unit in which we did this trial, in which we from which we recruited, get the nursing staff, medical staff, and things of that, within 24 to 48 hours, they were coming up to me and saying, is that doctor on a pill? I was actually surprised, because they didn't know this was happening, okay? And the answer was, well, yes, and they're able to say to me, is he on an SSRI? And I was saying, Yes, probably, you know, the thing was, they were observing the staff in a way that the staff don't observe them anymore. They're operating on theory. They're operating on the basis of, well, if you aren't well after, you know, a week or two, we have to wait for up to six weeks to you know, and then you'll actually recover. The patients could spot what happens to people, and had learned they had an expertise we didn't have based on observing people on these pills. And the same thing happens in prisons. I was interviewing a man recently who's in jail. He'd been on an SSRI and things went wrong, and he was able to say to me, the other prisoners can pick out who is on an SSRI and who isn't without being told.

Nick JikomesAnd can they do that very soon after they start the SSRI?

David HealyWell, they can tell people who are on, I mean, first of all, you know, the patients could tell, within roughly 24 to 48 hours after the person had been, after the nurse, or maybe the doctor had been, had begun taking an SSRI, they could tell, yes, we can see that this person's on these drugs, and actually, based on what they alerted me to, I've become able to stuff people around SSRIs.

Nick JikomesSo basically, it sounds like what you're saying here is that human beings, by observing each other and face to face, real world interactions, they can tell when someone's on an SSRI within a day or two, of them starting to take it, even if the clinical manifestations the potential antidepressant effect haven't shown up yet, because those often take weeks to manifest.

David HealyThe antidepressant effect is there from the start. It's either a good effect. It's what Arthur Carlson said, look, there's going to be a chill out effect, or there's not. And people can say, within one or two days, yeah, there's this drug is doing a useful thing for me, and I can see how it could be helpful. Or they can say, No, I haven't getting anything out of this. Are the effect? You know? Maybe I feel a chill effect, but it isn't something that I like. So

Nick Jikomesthis a standard story, a common story that I've read about and heard about in academic settings, about SSRIs. It goes like this. You know, on average, the antidepressant effects of SSRIs in those people for whom that effect will manifest can take several weeks to manifest, and this has something to do with, you know, the slow time course of neuroplastic changes being induced, and that's why it takes a few weeks for the antidepressants to show up. When they do show up, you're saying that effects manifest much sooner than that.

David HealyIt's a bit like alcohol or nicotine or benzodiazepines or whatever, the effect of these drugs is fairly obvious, fairly quickly, and it can be a good effect, and it's not the thing that cures you. Most people who get SSRI drugs, okay, are people who have a problem that's going to resolve spontaneously anyway. So the cure, so called, is not being brought about by the pill. The pill just makes things more comfortable for a period of time, or else it makes things a lot worse. It can do either.

Nick JikomesI see so something in your life is happening. It's making you sad, basically. But that thing will usually resolve. That stimulus will usually go away, and the SSRI, in some cases, can make that intervening period more bearable, um, but it's actually the the stimulus in your life going away that that will actually cause your your sadness to resolve, basically, and SSRI can be a tool to make that intervening period more bearable. Basically,

David Healyyes, exactly. And let me bring out a thing here, which comes back to the issue about, does it make sense to pay heed to what you tell me is happening to you on the pill, or should we just go by what the RCTs say? Okay, and you're the randomized control trials for these drugs. Compared these drugs to placebo, and they show that over a period of six to eight weeks, you know, yes, there are some people who seem to recover, you know, but it may take about six weeks. Well, yes, the recovery can take about six weeks, but that doesn't mean that it's anything to do with the acute action of the SSRI. The other point that comes into play here is people look at the data from these RCTs and say, Well, you know, the effect of the SSRIs is pretty weak. You know, they only just about beat the the placebo, the placebo effect, yeah. And people can go on to say, you know, well, maybe most of the effect of the SSRI group drugs is a placebo effect. Okay. Now, there is a sense in which that's right, which is that the part of the placebo effect is just the natural recovery effect, yeah.

Nick JikomesAnd I imagine it also has to do with the fact that, you know, if you're entering a situation, where you're going to see a doctor, you know that you're being cared for by someone who's paying attention to you, like all of all of those things have having sort of what you might call a natural healing component, because you know, you're not just off on your own, you're you're being cared for, yeah,

David Healynot quite, not quite, not quite, No, if you don't go to a doctor at all, and you get well after 810, 12 weeks or whatever, you're more resilient and less likely to get ill again in as a future. So natural healing works by natural healing once you get involved with the healthcare system, it's not going to be particularly natural healing anymore. People are going to do things to you, which, in the long run, may be unhelpful, but when we talk about the placebo effect, people think we're talking about things that are in your mind. If you talk to people who are on an SSRI either getting a good effect out of them, they say, No, this effect isn't all in my mind. This is a very real effect. And if you talk to people who have a bad effect on them, they say, absolutely no. This is not all of my mind. This is, this is a terribly real thing. That's that's actually happening to me. So I think we've got our discourse about what SSRIs do very badly mixed up, but also our discourse about what randomized control trials do badly mixed up, because it's not just a case of the SSRI barely beats, beats placebo, the one of the other interpretations you can put on the results from randomized control trials is there's a bunch of people who are suited to SSRIs and a bunch who aren't, and all things been equal, roughly only about half of us are actually suited to these drugs, and The other half aren't. So that's why the difference between the two arms of the RCT isn't that great. It's nothing to do with the placebo effect or whatever.

Nick JikomesYeah, yeah. It's just that you're failing to sort people based on their their baseline differences. Yes, yeah,

David Healyyeah. And you could, you could say, Well, look, what we're aiming to do is to to to see if this drug causes you to chill out, okay, and if that's what we did in the clinical trial, we would only need to run the trial for a week. We would need to run it for six weeks or more. But part of the reason we run the kinds of trials we did is because the pharmaceutical industry spotted the fact that, well, if our drugs can be shown to be placebo in a six week trial in people who are depressed. Rather than selling the drug, we can sell depression. We can make everyone depressed. And rather than saying, well, our drug just about works, and maybe you shouldn't be taking it if you don't feel that it's really helping you out. We can say no, the trial has shown it works. End of story. There should be no argument about this. The science says this works. And are you going to be the science, or are you going to be the anecdote? This person who's saying, No, this drug doesn't work for me. So

Nick Jikomestalk to me a little bit more about so you give someone an SS or. I There are acute effects that are felt right away. What do those look like when the SS the person is suited to the SR SSRI, versus when they don't? Can you be just specific and concrete about how that manifests in those that first 24 to say, 48 hour window?

David HealyYeah, let me take you back to the first 30 minute window. Okay, which is one of the interesting things about the exercise, is, as I said to you, Ava Carlton had this view that they work on the serotonin system, and they may suit some people and not suit others, like LSD, unlike LSD, which enhances sensory input, so that people hear things and see things in more acute detail, and often they appreciate it much more. SSRIs do just the opposite. They tune things down. They make us sensory, less reactive, nearly numb us. Now, one of the interesting things about RCTs is, you hear that, well, you know, these drugs have a primary endpoint that we've Well, RCTs operate on the basis of having a primary endpoint. We want to show these drugs are going to improve your score on a depression rating scale. And all of the interviews and everything about the whole trial is heavily focused in on this, and we're able to show that, you know, yes, on average, we have a an improvement in people who are on the SSRI compared with people who aren't on the SSRI. And you get told that the side effects of these drugs, well, they're either rarer than the primary effect, we've got a positive benefit risk ratio for the pill, because we know that you're at the benefits happening in most people who are on the bill that that is your mood's going to be helped. And the problems are less common than that, and they may actually be ones that only come on after a period of time after a period of time that lies outside the the duration of the RCT, and that's the reason that we just didn't pick them up. So that's the model most people have, but it's completely wrong. If you take an SSRI, the first thing that happens to you within 30 minutes of a first pill is you become genitally numb. From a sensory point of view, you have become numb and you don't feel your use the genital area is numbed compared with

Nick Jikomesthat area in particular stands out?

David HealyWell, that's the area that people have been most focused on. Some people become gently numb. We can show that they're generally numb, but they're not particularly aware of it. Okay,

Nick Jikomesso another way of saying this is that an area of the body which is normally quite sensitive to sensory inputs, becomes less sensitive to sensory inputs. Yes,

David Healyand it's not just genitals, it's your skin in general. Yes, yes. It's kind of, you know, there's less sensory input around the body generally. So, and this is interpreted by people as becoming emotionally numb, the sensory input is damned down. Yeah, yeah. Okay, so there they that's described this as being emotionally numb rather than sensorially. Yeah? What's

Nick Jikomesinteresting? What's interesting about that to me, given my neuroscience background and some of the things I know here, is what you're describing. Is what people report from their senses. What we know I'm going to sort of compress and simplify the neuroscience on this, but what people have been discovering last few years, especially around the serotonin system in mammals generally, is that one of the core functions of serotonin signaling is to gate sensory information, it sort of tunes how much, what you might call raw sensory information goes deeper into the brain and gets further processed. And so it fits quite well, I think, with what you're

David Healytelling me, yeah, no, no, no, sure, but let me push this bit further. Okay, yeah, I got involved in looking at the serotonin system way, way back. And if you ask me, while I was doing why I did all this, you know, I'd, I'd actually, first of all done medicine, but thought, before I go into the mental health field, which it would be a good idea to do some research. And the serotonin system was just vaguely coming on the map at that time. And, you know, I. Yeah, having an interest in therapy, actually talking to people, it was a little bit odd to be in a pharmacology lab looking at things like the serotonin system. And if you ask me why I was doing it, I would have said, well, you know, I'm interested in the philosophical problem about how the mind fits into the brain. Okay. Now, in particular, I was interested in how the female mind works, basically. But, you know, hey, I've realized that it's the issue we've got is not how does the mind fit into the brain? The brain is almost irrelevant. It's, how does the mind fit into the body? Because, and you know, the serotonin system brings the point out quite well, which is only roughly 5% of the serotonin in you and me is in what we call our brain, and it's in the reptilian bit of the brain, the ancient of the brain, if you look at what we think of as the human brain, or the cortex and things that there's some nerve endings there, But there's no serotonin based there, 95% of the serotonin in you and me is in our bodies, and it's linked principally to the sensory system. And as you say, what it does is it gates things. And you can open the gate with LSD and flood the brain with all sorts of things. If you chat to people who are into LSD and things of that, they talk about the mind a lot and at the brain a lot. They don't ever think that LSD may be acting on the rest of the body. Yes, the visual effects. They think, well, these were on the brain. There's a lot of serotonin in our eyes, which is not part of our brain. Yeah. Nobody stops to think about maybe the effects of LSD are as much in the eyes as anywhere else with SSRIs. They have huge visual effects. And talking to ophthalmologists, they assume this is all to do with the brain, because we've been we've been marketed to, we've been told the serotonin in your brain is low when your mood is wrong, you know, and this these drugs top that up, there's no serotonin that's abnormal in the brain when we get clinically depressed, once we take these drugs, your serotonin is going to be a lot more abnormal than it was beforehand. Yeah, but the effects of these drugs. When you listen to people and things that they've got visual problems, they've got genital problems, they have sexual dysfunction that may last for the rest of their life after they hold the drug. So

Nick Jikomesthe acute the acute effects, literally, the first pill that you feel results in many people, in this genital numbing effect, this dampening of sensation. What are the specific visual issues that people report?

David HealyYeah, well, one of the things that on the radar these days is thing called Visual snow syndrome, and that's comprised of a bunch of different things. First of all, people have flecks of white. They've got a, what we used to actually describe with old style TV sets, static in their visual field. You've got static, yeah. The other thing that goes with it is that you've got nice blindness that, you know, you can't really make things out if you if your job involves having to drive a car at night, you're in trouble.

Nick JikomesSo SSRIs are basically elegant. Have you

David Healyheard of this one? No, yeah, that's after images. You know you've got you see the thing you're looking at, and then you close your eyes and you see after images going on for ages. You've got a bunch of different things that are actually happening to your visual system, but that's they're the things that are most clear cut, and

Nick Jikomesthose things show up right away in the first day. No,

David Healyno, no, they don't. They may show up only after a period of time, but they also may endure after you've halted the pills for the rest of your life, just like the sexual problems.

Nick JikomesWhat? What percentage you know, roughly speaking, can you give us a sense for okay, if the most acute effects, the ones that show up immediately, the dampening of sensation in the genitals, is that rare? Is that common? Can you give us a sense for how common that is? That

David Healyhappens close to 100% of people, really, yeah, and this is this. This brings out.

Nick JikomesSo what? There or not, we're going to end up having the the antidepressant endpoint. That's something that you tend to see in almost everyone right away, yes,

David Healyand you're told by FDA, well, you know, the thing that's most common is that these drugs help you, the problems are quite rare compared with that. So there's a benefit risk ratio that's favorable to taking the pills. That's all wrong. You know, you may be helped by the pill. You absolutely will be generously affected by the pill, and you aren't being told about this. It isn't just that. I mean, you know, you get numb kind of genitals, your orgasms mute, and over a period of time, you lose libido, but also over a period of time, if you're male, your sperm count goes to the floor. If you're female, and you get pregnant, there's a much greater chance that you're going to miscarry. Are that there are going to be things wrong with the with the fetus? Wow.

Nick JikomesI mean, maybe it's a coincidence, but I know someone who, just a few months ago started SSRIs, and then not so long after that, got pregnant and miscarried. Yeah, yeah. Well, okay, but you're saying this just can happen anyway, right, right, yeah,

David Healyyeah, yeah, no, no, sure, but, uh, yeah, the pills double the rate, double the rate, wow.

Nick JikomesAnd then it affects sperm counts in men,

David Healyyes, yeah, they go to the floor, wow.

Nick JikomesAnd so, I mean, there's a there's a number of places we can go from here. But you know, the key thing, I guess, worth emphasizing repeating, is there are reliable effects seen in almost all people who take SSRIs that show up right away first dose, absolutely,

David Healyyeah, and they're more common than the supposed benefit, yeah, which isn't here, the kind of thing that you get here. I mean, you find people who come into the doctor and saying, these pills don't suit me. There are gentle issues or whatever, and the doctor responds by saying, well, that must be because you're depressed, loss of libido. The kinds of people that go to the doctor and get put on an SSRI don't have a depression in the sense of condition that's very severe and will cause your libido to drop. But way back when the first, first antidepressant group of drugs came on stream, in the late 1950s early 1960s some of those inhibited serotonin reuptake. Also, we were only using them in people who had what's called melancholia, people who are profoundly depressed, and otherwise they were going to get ECT, okay? Doctors giving them then could notice the fact, well, this person has lots of libido linked to their illness. When I treat them with these pills, the pills are also causing loss of libido. Doctors these days can't do that, right? They don't listen to the patient. They don't believe what they're being told, which is, Doc, a week ago, before you put me on these pills, my libido was great. The only thing that was keeping me going was I still had libido.

Nick JikomesI was because work is stressful, but I had libido. Yeah, yes, yeah, sure. Wow, interesting. So, um, so from your perspective, based on your experience, when people go on SSRIs, what should they look for in the first 24 hours to tell them to stop versus continue with the SSRIs? Is there a clear cut answer to that in your view?

David HealyWell, I think the thing is, you need to ask yourself, do I figure that this pill is actually suiting me in the sense of, is a good effect is, am I less reactive? One of my friends actually, at the doctor that the patients were able to spot is on an SSRI. He was able to say to me things like, Well, yeah, it's interesting. You know, you walk down the stairs, and the kids, they often have their shoes thrown around the place, and if I'm in bad form, I might give out them, you know, but now on the drug, he'd walk down the stairs and his shoes could be all over the place, and he'd sail by without being bothered. Okay, so that's the kind of thing, in a sense, we're looking for. If you don't have something like that, you shouldn't really be on these pills, you know. So you're the one who needs to be able to judge, is it producing an effect which could be useful, and if the effect which could be useful, do you appreciate it? Yeah, if you don't again, maybe it's not for you.

Nick JikomesYeah. I. I I think I fully comprehend what you're saying here, but I'm going to ask you this anyway, just just to bring it home for people. So this notion that the the antidepressant effects of SSRIs is delayed and takes, you know, six or eight weeks or whatever, to show up, you're saying basic basically, there's a real issue with that, and you shouldn't need to wait that long and that you can sort of discern whether these things are directionally, probably going to work or not very much, much sooner than that.

David HealyYes. And let me add two more things into it, which is, your family needs to know about it. You know, your partner, your kids, your parents, whatever, because they'll be able to spot things as well, right, things that you might not notice. Yeah, and they'll be able to spot is this actually suiting you or not? And they'll often actually describe, well, you've had to change personality. Yeah, it isn't one that we like all that much, yes. But there is a further aspect to all this, which is when we when the companies began doing RCTs on these drugs, they became aware pretty early on it was going to be tricky to show that they worked. You know, they had to be awfully careful. They couldn't recruit people who are very severely depressed, because SSRIs aren't particularly good for people who are severely depressed. Okay, so they needed to recruit a bunch of people where the placebo response is going to be pretty high, people, right? Mildly, mildly depressed. But in order to be absolutely sure they're going to get a positive result, they introduced the drugs at a toxic dose level. When we hear the you know, the fact that Prozac is in a 20 milligram dose to a lot of doctors and a lot of other people. That sounds like a low dose. That's a toxic dose. What

Nick Jikomesdo you what do you mean toxic? Lily

David Healydid trials which showed that five milligrams was just as good as a 20 milligram dose. Eli Lilly. Eli Lilly? Yeah, it's when you use a 20 milligram dose of Rosa you are occupying all of the serotonin reuptake sites beyond the point where it's doing any good. So if we were operating on the basis of saying to people, Look, you should only be on these drugs if you get an effect and a five milligram dose that a figure suits you. Okay, we shouldn't be giving you a huge dose in order to try and knock you out all those you know, what's,

Nick Jikomeswhat's a normal starting dose that would get prescribed

David Healyto someone? Well, the normal dose of Buza, which was the only dose you could get for years and years, was the 20 milligram dose. So

Nick Jikomesit started that way, because they designed the trials that way, because they wanted to maximize the probability of seeing an effect in people with mild depression, because the whole thing was being engineered to try and get the outcome they wanted. Yes, and so initially everything was done on 20 milligrams. And so that was the only that was the only game in town, even though we later figured out that five, five later, it isn't

David Healylater. They did trials on the five milligram dose before was marketed, and had just as good a result. But in terms of what they were going to show FDA, they figured, we're not going to take any chances with a five milligram dose. We're going to just go with at the 20 milligram dose. And also part of marketing afterwards was, well, you know, let's make it simple for doctors, just one dose, one dose, one dose, that's all you do,

Nick Jikomesright? Because that's probably going to be most conducive to using it as widely as possible. Willing to use it? Yeah, sure. So. So this, this brings us to another issue I wanted to ask you about so Eli Lilly had data on the five milligrams and the 20 milligrams, but they didn't have to show all of it to FDA. How does, how does that piece of all of this work? In terms of pharmaceutical companies do these trials, they do this research, but they don't have to show or share all the data, even with the FDA.

David HealyYeah. Well, you need to ask yourself, what do FDA do? And FDA are a bunch of bureaucrats. They're a bit like the Federal Aviation Authority, the FAA, who guessed the paperwork from Boeing about the latest plane, and they're just looking at the paperwork. They're not flying the airplane. They're not involved in the design of the airplane. They're just trying to tick boxes. Have Boeing done the kinds of things? That they ought to be doing, and the FAA are only interested in a useful paper trail.

Nick JikomesYeah, well, you fulfilled the requirements of the protocol. Of

David Healythe protocol, sure, in terms of keeping people safe afterwards on this plane, FAA have nothing to do with it's the pilot who, as I say, if things go wrong with this plane or with the system of all the planes going in and out of airports, and things that the pilot gets worried, he or she will say, Well, look, until this is fixed, I'm not going to fly again. And all of her colleagues are going to say the same thing, you must fix this, or we ain't gonna fly against doctors. Don't do that. In theory, they're in the same position as pilots, which is they're the people who are going to keep you safe. This drug has gone I mean, there's a bunch of paperwork that has gone into FDA. FDA has tick boxes. They haven't got in touch with the patients recruited to the trial. They don't even know if all the patients in the trial supposedly exists. They certainly don't know that. They've got all the trials that the company did. They don't look at the healthy volunteer trials, which are, you know, the ones that are really going to show what the drug does. You know, if we have a trial where we give this drug to people who are anxious or people who are depressed, yeah, there can be a bit of confusion if people become suicidal. Well, depression can cause that as well. But if you give these drugs to healthy volunteers and they become suicidal and commit suicide, which they have done, right, it's difficult to blame the illness, right? Okay, but FDA, don't look at these healthy volunteer drugs. I mean, it's read some paperwork and tick a bunch of boxes. I mean, it

Nick Jikomesbasically sounds, it sounds like what you're saying is that the FDA, they they do their job in the sense of paperwork is submitted to them for by drug companies, and they will read the paperwork, they will look at the paperwork, they'll make sure it's filled out properly. But there's no sort of extra or further investigation of whether or not the paperwork is tied to reality, if it's actually what it says it is. There's not a lot of looking under the hood beyond what's submitted. Yeah,

David Healyit's very much a case of FDA there to license the use of certain words. It's the food and drugs agency, so one company can bring them some brand stuff, which they want to call chocolate, yeah? And FDA has a criterion for chocolate, which is, it's got to have so much cocoa kind of solids. I've never quite

Nick Jikomesthought about this. It's an agency that is regulating the use of language, yeah,

David Healyif you've got the right amount of cocoa solids, you can use the word chocolate, but FDA, aren't in the business saying this is good chocolate. Okay? The company that wants to market this as chocolate are the ones that are going to go out there and try and persuade you that our chocolates much better than any other chocolate you can get. Okay, it's the same with with butter. You know, they've FDA, I've got a slab of yellow stuff. Is it butter? Well, it depends on the animal fat content, whether going to let you use the word butter or not, but FDA aren't going to tell you if it's healthy or not butter. It's doctors who are going to maybe work at this. You know, it's about the same with, well, it is the same with all of the antidepressant and every other group of drugs. If you want to use the word antihypertensive, FDA have a criterion, it must lower blood pressure. We if you want to use the word antidepressant, they have a criterion, which is it must lower a rating scale score. It's not keep you alive. It's not save lives. It's almost nothing that goes through FDA that saves lives, really, yeah, there are more people die on antidepressants in the trials submitted to FDA and antipsychotics than die on placebo.

Nick JikomesAnd you're saying that a lot of that the reason that's happening, a big piece of the reason that's happening is the way that people die. It's like, it's like, what you said with the SSRIs and depression, it's like, oh, they committed suicide. Well, that was because of their depression, not because of the medication for the depression.

David HealyWell, that's the way the company can play things afterwards. FDA are just bureaucrats. Their job is not to think. It's to make sure that when things go wrong, we have a paperwork trail that means you can't shoot us. Can't take us out and shoot us. Yeah,

Nick Jikomeswow. And so how much like, what can you tell me about, you know? So let's just assume that miles, the nurse, have a basic idea of the biopharmaceutical pipeline, right? You have to do preclinical research. You've got a drug candidate, then you do your phase 123, trials and so forth. You eventually get approval. The you know, what we're led to believe is that if something is an approved drug, you know, the science is rock solid. All in the clinical trial. Results all looked good, and sort of all of the results were analyzed. What can you start to tell us about, you know, how the data is sort of massaged along along the way, how certain pieces of evidence are maybe left out, that aren't even analyzed, such that it looks like all of the evidence looks good, and you tick all the boxes at the FDA, and then you get approval, but, but in fact, all the evidence was was not even looked at in some cases.

David HealyYeah, in what you need to appreciate, I think, is that the studies companies do to get a license are essentially assays. They're not randomized, controlled trials. They're randomized, and the control that way, but they're assays, rather than trials done to inform clinical practice, and as I say, they get the paperwork into FDA, who don't check if all of The people in this trial actually existed or not okay, if you were FDA and really working hard at the job, you'd imagine, you know, you'd look the paperwork and, you know, you'd notice, hey, this guy in this trial died from burns. Well, you know, if you're just working through the paperwork, you can say people die from burns. You have accidents that happen in any group of a few 100 people. You know the companies are supposed to write an account, which gives the person in FDA a bit more detail. If a patient has died from burns, R has ended up going into hospital for whatever reason, and in one of the Pfizer trials, I should probably hop back and just introduce this note for you. Okay, when Zoloft launched in the UK, I chaired one of the launch meetings for Pfizer, okay, that was at a point before I knew what I'm going to tell you next. Okay, but at the launch meeting, I thought, You know what I'm what I say is that this group of drugs are new, and the serotonin system is pretty primitive, and we're going to learn things by using these drugs that we didn't ever know before. And I thought this seemed to be a reasonable thing to be saying, you know, it's going to be exciting. Life is going to be fun. We're going to see new things, which will kind of provide the basis for new drugs. This was just after Viagra had been discovered by Pfizer, by a bunch of people who when Pfizer thought the trial didn't work all that well for heart problems, but guys weren't happy to give the drugs back, because they noticed he was doing something interesting for them, you know. So I was trying to play on that theme. You know, things could be interesting here. We're going to see things we haven't ever seen before. But anyway, FDA aren't looking at it like this. You know, what is there in this dossier that's going to tell me things I didn't know about medicine beforehand? Okay, so you've got guy dies from burns in a Pfizer trial, and when things like this happen, the company are supposed to write things up to explain a bit more. Okay, it looks pretty clear that FDA didn't look closely at the whole thing. They just said, Oh, death by burns. When you read the account of what happened, you found this guy became agitated on one of the drugs and wanted to kill himself, and poured gasoline over himself and set fire to it, but he only died five days later and gets coded as death by burns rather than death by suicide. Now that's the kind of thing that should be happening. And if people in FDA were awake, they'd be reading these things and saying, Hey, wait a minute here. You know, I need to get hold of this guy's wife and get a little bit more from her about what went on. But they don't have the contact details people. Actually, I've got a great story. I can tell you about that, but anyway, let me just just add one more thing in first which is, in theory, Pfizer have to, you know, write an account of what happened to this man who died from burns. But around the time he died from burns, they realized, you know, there's other things we can do, not just them, but all of the companies realize, you know, if we've got a kid going on an SSRI, as one kid actually down in in Texas going on axle, you know, a week or two later, he's out in the street waving a gun around, threatening. To kill people, so it gets picked up by the police and gets brought to hospital. So there should be an account of what happened. There isn't, technically, if you've got an adverse event on the drug, there has to be an account of what happened. But if you decide, if you're GSK, as it was in this case, and you decide, well, this kid, you know, he must have had bipolar disorder. We just didn't realize that, and he shouldn't have been in this trial at all to begin with. Throw him up. You don't have to write anything. You just throw him out of the trial. And he disappears. And in this trial, where 87 people actually go on Paxil, and there's more people actually going on Paxil who become suicidal and have behavioral changes than on at the placebo. There were four kids that disappear like this, all taking Paxil, but FDA to this day know nothing about it.

Nick JikomesBasically what you're saying is the technicalities involved here allow companies to throw out data by, you know what? We'll just call these, these tricks, and that makes the data look better than it actually is. Yes,

David Healyand furthermore, coming back to the the issue about RCTs. And the do we pay more heed to the RCT are the reports from, you know, the person one of, one of the things that I've been actually involved with for ages now is post testers for eye sexual dysfunction, Psst, as it's called, okay, yeah. And one of, well, the person that put this on my radar first a quarter of a century ago, okay, she came into me one day, this lady, and I can still see her and and she told me, Look, I'm not able to make love since I was on this pill. And I said, Sure, you know, these things happen, but once you come off the pill, things will be fine. And she looked at me and she said, I've been off this pill for three months, and I can take a hard bristled brush and rub it up and down my genitals and feel nothing, okay? So my response was, you know, holy fuck anyway. And at that point, I mean, still we had no treatment for her, okay? But here's the point of trying to make around the time she came into me the companies up till then, when you were on any of these pills and something like this happened to you, you got in touch with the company doctor. Either your doctor got in touch with the company doctor, are you got in touch with the company doctor and said, Look, you know, I'm gently numb, and I've been off this pill. And you know, it all began when I was on the pill. It's still there now, months later, and the doctor would try and work out whether there was any other way to explain, you know, the problem other than the company drug had actually caused it okay, and they routinely, well, not routinely, but they often actually decided. Your company doctors actually decided, based on interviewing you, when you said something like, I can take a hard bristle brush and rub it up and down my gentles and feel nothing, that there's no other way to explain it, given that their drug can do this to begin with, when you go on it, and there's no condition in medicine that causes this, you know, people to be generously numb like this, yeah? You can't just say, Oh, that's great pressure. Yeah, yeah. But around this time, this is the year 2000 companies had begun arguing in court that the only material accounts is the randomized control trial. Material if it's not in the randomized control if it didn't control trial, if didn't show up there, then it doesn't exist. Are drugs not causing

Nick Jikomesit? Yeah? Okay, yeah, you can basically disappear evidence, yeah,

David Healybut what the legal teams working for the pharmaceutical industry realized at this point was, Well, if that's an argument in court, we can't let company doctors decide in the case of this anecdote that the company drug has caused it. They've got to say, we've had a report of someone becoming gently numb. I'm going to pass it on to FDA. Okay, now, years later, I get involved in trying to collect lots of material on people who've got pssd. And one of the things about people with pssd is until all three. Simply, nobody wants to let anyone else in the entire universe know that God pssd was a bit like having AIDS, you know, you didn't want to let anyone know that you had this problem. So they didn't. They weren't happy at letting their names out. But I had reports on 80 people who were happy when I told them what we were going to do was we're going to send the reports we have. What we'd like to do is send the reports we have on everybody who's got psst to the European regulator and to FDA, and we'd like you to leave your names on us. We'd like you to consult a doctor, also your doctor, the one who put you on these pills and asked him or her to write a note as well, saying, Well, you know, we don't know if the drug has caused it, but we can't see any other way to explain it. Okay. So we got about 30 or 40 doctors doing that as well, and 80 people leaving their names on it, which was a big thing for them to do at this point. So we sent the material to FDA, who are still sitting on it five or six years later, we send the material to the European regulator, whom I happen to know at the time. Okay, so I was able to get in touch with them and say, Look, did you get all of the material? And he said, Yes, they did, and that I'd be pleased to know that we they, as per procedure, when they got all this material, the first thing they did was to remove everybody's name. They were told in the covering letter, the reason you're getting people's names is so you can contact them. Here's their email address, here's the phone number in order to work out, we don't think you can decide the drug is causing the problem unless you interview people. Wow. FDA and Ema don't have anyone who can get in touch with everyone who reports things to them.

Nick JikomesSo by manipulating procedural outcomes, this was prevented from, you know, actually being investigated. Yeah.

David HealyWow. It actually comes back to the point, if you're going to decide on cause and effect, it's not randomized control trial that's doing it, that's going to do it for you. It really has to be an investigation. You know, since somebody actually talking to you who knows a bit about medicine and knows a bit about the drug, and says, Well, the most reasonable explanation about what's happening here is this drug is causing this problem in this person, so maybe awfully rare, but

Nick Jikomesyeah, a theme of what you've been saying, I think, is that the bureaucrats in these agencies simply don't have incentives to be motivated to do investigation, they are simply going to process paperwork, and therefore they can be easily guided or manipulated by the clever use and engineering of paperwork, by the people submitting

David Healyit. Yeah, and but to go even further, it's it's not the bureaucrats responsibility to lead. You've got a bunch of professionals who make a living out of the fact that you can't get these drugs from anyone else, other than from them, and it's their responsibility to be doing, you know, to lead in this, and to stand up and say, Well, look, we aren't going to prescribe your drug anymore. Doctors, in a sense, are in an extraordinary powerful position. If nobody can get the drugs other than them, can get the company drug other than them prescribing it, they have a lot of power over the company. You know, if they actually say, Well, we're seeing a lot of people with pssd, unless you tell us a little bit more about what's going on, or when you realize this is happening first, and we include in the material that we give people an account of what the risks are. We aren't going to give this drug, but they don't do it. And as a result, the only thing that makes doctors wake up slightly, is when I say to them, Look, if the dogs work as well as you say, and there is three of problems as you say, you're going out of business. Nurses are cheaper prescribers, pharmacists are cheaper prescribers, and we'll have robotic prescribing soon. I

Nick Jikomeswant to ask you more about pssd, because I had, I had people request this topic. So post SSRI, sexual dysfunction. You talked about the genital the muting of general sensation that most it's you said most people feel this right away on SSRIs. So for pssd, let's start with the basics here. What is this in concrete terms, in terms of how it manifests, how common is it? And let's just start there. Yeah, well,

David Healyclose to 100% of people who take these drugs will have some genital numbing. Not everybody will be aware of it. Most people will be. And it isn't just that. There'll be a. Aware of it. You know, the story really takes off in the late 1960s early 1970s when SIBO gagi, making a drug which we now know is a potent serotonin reuptake inhibitor, clomipramine, realized that the antidepressant dose of this was 150 milligrams, but in a 10 milligram dose, it could solve premature ejaculation problems for men by making their genitals that bit more numb. And if you took the pill, a 10 milligram pill, just a fraction of the antidepressant dose, 30 minutes before you made love, you were going to have much more successful time, and they put articles in the newspapers about how your partner is going to love you even more, because she is going to think, Wow, that was pretty depressing when he came so quickly, basically. So that was well known back in the early 1970s it was well known in the early 1980s that and I can remember a very arresting talk about a behavior therapist in the UK called Isaac marks, who figured that behavior Therapy is the best treatment for OCD was being muscled at a bit worried about the fact that phebic IV were also marketing clomiphemine for OCD, and it is a good treatment for OCD, okay, and this is the drug from which the observations that it can make you less reactive came. That led to the creation of the SSRI group of drugs. Anyway, COVID was muscling in on the OCD market, and Marx was was not terribly keen on all this. And he said, you know, there can be awful problems linked to this drug. He was treating a nun for OCD, and he said, when they stopped the drug, she was left with permanent orgasms afterwards. So just the opposite, just the mirrored image of pssd, and it's what's called PGA D, persistent genital arousal disorder. So there's

Nick Jikomesa persistent sensory issue, and it can go in either direction.

David HealyYes, it's mostly you get numb, but you can have just the opposite. And this is, as it were, an akathisia of the genital area. Okay, now you can imagine this happening to a nun. I mean, this is the other reason that the image kind of stuck for me, this was the mid 1980s so we knew that persistent host treatment issues could be happening as far back as then. In I was involved in a trial for SmithKline, Beecham and Axel in the early to mid 1990s and they were going to look at at the sexual effects of Paxil compared to clomipramine, which was the other drug it was being compared with. And they knew clomipramine was going to cause problems, okay, but when they, I mean, they drew up, you know, at the protocol for the trial, and was going to be specially designed questionnaires to investigate the sexual aspects of all these drugs. And we the investigators had all these things to look through and things out. And there was an investigators meeting in Monte Carlo. Would you believe on the Riviera, Mediterranean, slash hotel, etc, etc. All the investigators were there, and we were told, Look, don't complete any of asexual questionnaires. Just don't leave them out. Okay? And we didn't really ask the questions. You know, the kind of surroundings were too nice to bother the company was saying, why not ask these questions? It later became clear to me that when I got a chance to see some of the healthy volunteer trials that smithland Beach and had done on this in the mid 1980s 10 years before this, they had found serious sexual problems in a bunch of young men. Almost all of the young men in the trial were bitterly complaining about the sexual problems on this drug after being on it for only two weeks. And it was clear from the trial as well that some of these problems kept going for at least a week or two afterwards. We don't know how long they kept going, but after they stopped, they monitored people for a few weeks afterwards.

Nick JikomesOkay, can you please give people just, I want to give people a concrete sense, you know, let's say someone's on an SSRI for six or 12 or 18 months, whatever it is, you know, something in the normal range for how long the average person is on these things? How likely is it that someone's going to. Experience. Pssd, how long does it last on average, and is it reversible? Is it fixable? If it doesn't go away?

David HealyYeah. First of all, let me answer the last question you've asked. It's not, it's not actually fixable. Wow. We've got people who have had the problem for for 20 or 30 years, well after they've stopped. There's a number of people who can recover, who can recover spontaneously, but this seems to be relatively rare. It's unclear how kind of long, how big the group who actually do recover is. It's not permanent damage in that what people can find is that if there are other drugs, and often when they stop the other drugs, they can have a window of a few days or a week or so where things do seem to improve, and they say, Oh, great, you know, things are better, and then they relapse again. So we've got a situation where it is permanent, and in a sense, isn't, if you see what I mean, it's not permanent damage. But effectively it is, in the sense of, we don't get things back right. But there is the hope that, based on this, that there's something there that can be put right, if we only have research happening on it to really work out what's going on here, and how do we put it right? There is no research happening on us.

Nick JikomesSo how so? So it can be permanent, or very long lasting, in the people who experience pssd So they stop their SSRIs sexual dysfunction lasts after the drug is out of their system. And this can last a very long time, potentially even decades or forever. Maybe, how many people experience pssd? Is this the majority of people that are on SSRIs, long term? Is it 5050? Is it, you know, a sizable minority. Can you give us a sense for that? Yeah, I can.

David HealyThere's very little work on this. There is one piece of work where crowded in Spain 20 years ago are so looking at SSRIs and looking at this was before pssd came on the radar. So, you know, they weren't actually trying to look at Psst, but say they looked at the issue about how many people recover normal, normal sexual function after they halt the SSRI? And the answer they came up with is, well, roughly 50% the other 50% don't recover. Bull, how full, full, full function of the kind that they had beforehand. Whether that was full blown psst are just you don't get all the way back to normal, is unclear, but they didn't have psst on the radar for them. One of the complicating factors in all this, of course, is if you're on the drug for five or 10 years or whatever, and you've aged, right, you may start thinking, Well, I'm just a bit older, you know, maybe this is the reason that big

Nick Jikomesolder I've been married all these years. You know, there's that comes out of that,

David Healyyeah, yeah. But let me just bring out a feeling for how actually profound this can be. I know of 20 people who cannot commit suicide because they've got pssd. And I'm sure there's a lot more than that in terms of people who have the opposite effect the PGA D problem, and this is more female than male women

Nick Jikomescan get so on. You said you cannot. You met people who cannot climax. What did you say? No.

David HealyIf you look at the opposite problem, people have got PGD. That's persistent genital arousal disorder. You know, you're having unwelcome and unpleasant orgasms the whole time when you drive the car, the vibration of the car can trigger an orgasm. Okay, this can be the kind of thing that's terribly uncomfortable from a social standpoint. Yes, you got a lot of people going around the place with frozen bags of peas to sit on. Wow. And you've got a bunch of people who go along to pain clinics and opt for a clitoridectomy. Oh, wow. So the problem so these are not minor problems. Are terribly serious problems, okay? And as I say, there is almost no research happening on either pgad or pssd.

Nick JikomesWow. So, wow. So it's a big it. This can and does happen to a lot of people on SSRIs?

David HealyWell, you've got a bunch of people who stay on SSRIs. And they stay on SSRIs because they can't get off I mean, these are drugs. Once around them, a proportion of people will simply not be able to get off them. Some people can get off them. Very large proportion of people can't get off them. And this is one of the reasons why we don't know how common pssd is, because in order to say you've got pssd, you have to get off the drug. And what happens when you get off the drug is the sexual problems you've had on the drug can get worse, not just that. They keep going, they can get worse, but when you're on the drug, you're not going to be functioning the way you would have functioned if you weren't on this. Yeah,

Nick Jikomesyeah. And so like, what are the main reasons that people struggle to get off of SSRIs? Is it because of things like, what you just said, where some problems get worse and they say, Okay, well, might as well go back on the drug because it's not as big of a problem.

David HealyWell, it's when you go on the pills one of the one of the things that can happen when you go on the pills first is you can become very agitated, you can become suicidal, you can become homicidal, etc, etc. Or you can go the drugs, and things can be relatively okay. And when you try to come off them some months or years later, that's when you become agitated and become suicidal, and you kind of conclude, as my doctor told me, it's a bit like insulin. I've got a lowering of serotonin. It's a bit like diabetes. I need to continue a treatment for the rest of my life. And you know what you find when you come off the drug is you become suicidal, you go back to the drug, and almost instantly, the problem clears up. I see. So it persuades a lot of people that, yes, that view about what's wrong with me was right, and I need to remain in these things the rest of my life. Wow. Okay,

Nick Jikomesso I always, I always thought, like the story I always heard was, you know, SSRI, you know, it relates to what we talked about in the beginning. You know, the sort of the cartoon story you often hear is, you know, SSRIs, take six to eight weeks before the antidepressant effects kick in, because neuroplasticity has a slow time, of course, and in that intervening period you might disinhibit behavior, and that's why you get a spike in SSRI and do suicide at the beginning. But you're saying you can also get a spike in suicide if they try to come off

David Healyyes and the Yeah. This is yes, and if you change the dose, which is common, it isn't just when you actually come off, it's when you're trying to come down. You may become very actively suicidal. It's when you go on the drugs first. You may not have a great effect, but you may not be all that bad. You may not be suicidal. And the doctor thinks, Well, you're not as good as we yeah, as you could be. Let's double the dose. You can become suicidal there as well. But let me, let me throw a further thing into the mix here, which we've kind of skipped over. You may want to just, just drag it into the conversation. You asked me about how the companies can hide things, and we've talked about FDA and how easy it is to fool FDA and things of that. The other aspect to things, of course, is that most of the medical literature reporting company assays rather than trials, which appears in the New England Journal of Medicine. Actually, this is very interesting. A very interesting story I can tell you about this which appears in the New England Journal of Medicine. In general, you know the various books of the Bible, and they're ghosts written. It's not just that FDA don't have access to the data, in the sense of the people who are in the trial. It's the articles that companies publish have been ghost written, and often, FDA know that the company has published an article about their trial which says the drug worked wonderfully well and has no problems. But FDA have seen the data from the trial and not just seen the data. They haven't really looked at the data. They've been told in a covering letter by the company, our drug didn't work in this trial, and it caused all sorts of problems. Okay, so FDA is seeing an article in the New England Journal of Medicine, which is saying just the opposite. You know, the company has written to FDA and told them our drug didn't work in this trial. It's got an article in New England Journal of Medicine, which says our drug worked wonderfully well and is free of problems. FDA know this is a fraud, okay, but they agree. They've responded to us, Kay, for instance, who written them and said we've done three trials in teenage kids, all negative in. Are teenagers who are depressed. All three trials negative, okay, but one of them has actually been published in the leading journal in child psychiatry saying just the opposite. Okay. GSK, say, you know this trial was negative. FDA agree, we've looked at the trial and appears to be negative. We also agree we're not going to mention this in the label of the drug. What's going on? This doesn't make FDA look awfully good, but the FDA response is it's not our job to police the medical literature, and it's not so companies can write fraudulent studies with leading names, prophets of psychiatry from Harvard and Yale in the very best journals, right, which

Nick Jikomesenable them to submit the paperwork to the FDA, and They will process that paperwork.

David HealyWell, FDA won't No, no. This is all about the marketing. You're the sales. Yeah. What happened in this particular case was the article about giving the outcome of the trial had been published before the data went to FDA. It was only when the company had published the article and there was an increasing amount of sales of axonal for teenagers who are depressed that they thought, you know, we don't realize. You know, FDA will probably approve this drug anyway, even if, you know, if we send the data into them, and even if we tell them the trial was negative, yeah, probably still going to license us to say you can use this drug in teenagers who are depressed. Okay, now I have an interesting story which ties all of this together. There was a group of people, and you probably know, actually, you've interviewed one of them, Joe Moncrief and Mark kind of Horowitz and a few other people. Wrote an article for far as far bar a journal called there was an article for social science in medicine, which is a good journal, and they have a it's it's a bunch of journals these days, one of which is for mental health issues. And they wrote an article on the lowered, lowered serotonin idea. And they looked at many different articles and books where there were claims that, yes, there's a well known lowering of serotonin, and people were depressed. And there was one, I think one of the only one of the 30 articles that they looked at, which said no, that there is no kind of lowering, okay? And they said something to the effect of, you know, we've looked beyond these articles, and actually, when you look at it closely, there isn't really any evidence that there's anything wrong in the serotonin system, and people were depressed. Okay, so the journal asked me to review the article. I did, and I said, Well, you know, this is interesting, and it's, I mean, it is absolutely right. There's nothing wrong with the serotonin system. We've known this for a long time. But the interesting thing about this, it looks like the 29 of the 30 articles which all claim that it's well known that there's a lowering of serotonin in people who are depressed, all look like they've been ghostwritten. Okay, the one article which says just the opposite, I happen to know the people involved, and they can't afford to go so,

Nick Jikomesright? So naively, if you were to just look at the literature and say, Okay, let's look at all of the studies that are relevant to this question, and we're going to tally the results, and we'll use a democratic vote. So, oh, the vast majority of studies say this. There's only one study that says that if you do things that way, you're going to you're going to believe the one thing, even though, always,

David Healyif you're a ghost writer and you're working for a few different companies, you're going to sign, I mean, you're going to have tropes like, well, let me put it like this. Let me go back to the basics. Back when I was talking meetings for the pharmaceutical companies and links to that, I agreed to get involved in a meeting. And shortly after, I mean, I was told was actually going to be in London. It's going to be recently, high powered meeting and things like this. And I said, Yep, sure, have to get involved. And a week later, I get an email saying, you know, and we're going to try and publish the, the the proceedings for the meeting, so you, you know, you, you,

Nick Jikomesyou're on the record. Well,

David Healyyou'll actually have to, you'll have to actually write an article. Okay, so I said, Fine, perfect. Then a week later, again, I get a further email saying, and here's your article. And I said, I kind of dropped a note back, saying, Look, when I agreed get involved in this meeting, I had an idea. I'd be asked to do an article, Anna had some ideas about the article that I'd like to write, and I've got a more or less done. I'll email it over to you when it's finished. And I did, and they looked at and they said, Oh, this is interesting. This. This isn't bad. I think we'll have it okay, but there are some important commercial messages in the other one that we emailed over to you, and we're just going to change the name of the author. It remains well, as they used to tell the story to people. Look, if I took a bunch of my articles and put them on a table, they're people who thought they knew my work and asked them to pick out the article that I didn't write, they wouldn't have picked out the ghost written article because it was wonderfully done. It was like tone of voice who said the kinds of things that I say. It was Healy references. And these are good ghostwriters. Absolutely, they're PhDs. They're

Nick Jikomesprobably, they're probably well paid to do a good job, yeah. But

David Healyin the end, both the article that I wrote and the other one that was written for me got published, and they only changed one word in the article that they'd written for me. They just changed the name of the author. It's a Healey article with Healy references, but they just changed the name of the author. Be it. But for them, it was actually important, because it's important to commercial messages in it. So when I got in touch with Bucha with my review of the the Moncrieff et al article, I said, Look, you can kill two birds with one stone here, and you can have an article who says that the serotonin theory is just crazy, and an article which points to the likely ghost writing input into all this, which is, you've got ghost writers who Ha, whose job is to include certain important commercial messages in whatever else they write. It could be wonderful otherwise, right? But they'll have a few choice nuggets, because industry can't claim there's any lowering of serotonin in people who are depressed. But in their adverts, they can have David Healy say there's a lowering of serotonin in people who are depressed, provide us a footnote to a reference, right, right, right.

Nick JikomesWe're not saying that we're just, we're just, we're just showing you the literature Exactly,

David Healyexactly. Now, the interesting thing about it was, Jo and her co authors decided this was a bit too risky. They didn't want to go there. But the editor of the journal who'd sent me the article to review said, this is a really interesting point. Do you want to write a commentary, which we'll also publish with the mongree article. I said, Sure, fine, and I wrote a comedy short commentary, oh, less than 1000 words I forget. I mean, really shortish, and emailed it to them. And the editor got back in touch with me and said, Well, you know, I've been told by my co editors that we can't publish this. She refused to specify exactly. Why not. She just said, this just isn't yet the time. Now, the thing about it was that I'd made the point about the serotonin field, but said it applies to all of medicine. You know, it's going to apply to the COVID vaccine trials as well that have just recently appeared in the New England Journal of Medicine, right? Which I know what goes through. I know the ghost writer, and I know some of the people who are injured in the trial who disappear in the published. Who was the ghost writer? This woman called Sheena hunt. Sheena who lived in lives in New Zealand. And what does she? What

Nick Jikomesdoes she do? Like, why was she the ghost writer? What's her background?

David HealyWell, most ghost writers, as I said, are PhD, yeah. And the ghost writing issue, let me just bring out a point here, which I think is nice. The ghost writing issue became a big deal around 2004 when, with the trials done on antidepressants in kids, became clear that every publication said that these drugs worked and the data, when we got hold of it, including the Prozac data in kids was negative, okay, and it was also clear that everything was ghost written, yeah, okay, so there's big fuss about ghost writing, and the problem has been solved by including the names of the ghost writers in small print. Right, wow. End of the article. But that's seen as the solution. I mean, people were saying the problem with ghost writing is you're not letting, I mean, you're making the ghost a ghost, you know, yeah. Nobody gives them any credit of any sort, yeah. So we're just going to mention the name. We're just going to name the ghost and yeah. Now it's all when you know, yeah, but we aren't getting to grips with the fact that the important commercial messages, they're still there. Yeah.

Nick JikomesDo you have a hard stop at the hour here?

David HealyNot exactly a hard stop, no, but at some point, yes, of

Nick Jikomescourse. I just want to ask you one more question, one more topic, and I'll let you kind of steer it. But this is something that people wonder about and and speculate about, I think, reasonably, you know, and that's the issue of suicides and violence and how that relates to SSRIs and maybe related drugs. One way this manifests that you you know, I've seen this in social media, for example, you know, obviously we've had, we have a mass shooting problem. They're happening at a higher frequency than they used to. Certainly, I remember being in fifth grade when Columbine happened, and that was like, you know, the first big one. And then, you know, they just became more and more common. I hear about them, you know, all the time now. You'll often see on social media, for example, people will post, you know, a collage of like, 20 faces, and, you know, they'll say that they're all on SSRIs or antidepressants of some kind, and try to make the case of, well, there could be a relationship here. And you could say, Okay, well, maybe they just cherry picked examples, and this hasn't been systematically studied. What can you tell us at a high level about SSRIs violence and a potential connection to things like mass shootings? Is there a connection here? What should we know?

David HealyYeah, yeah, there is. Let me preface this by saying, first of all, I prescribe exercise. I don't not okay. I'm not into other kinds of therapy. I'm into using drugs to help people where appropriate. The you know, the being able to use a drug means knowing when not to use it, and it means knowing when to actually to halt when it isn't suiting a person. Okay, maybe switch to, you know, whatever, okay. But the yeah and in terms of people actually becoming suicidal on SSRIs, first of all, one of the difficult things for companies that anyone here to explain is the healthy volunteers who've actually gone on to commit suicide on these drugs in very brief trials, people who are normal, deeply Christian, totally against the idea that that I might kill myself, who kill themselves on these drugs and kill themselves withdrawing.

Nick JikomesSo it's not just people who are already on the brink or who had attempted suicide before.

David HealyNo, no. People who are going to college need a bit of money to help pay the fees or whatever. You know, pretty healthy people. Yeah. So in terms of people who have gone on commit suicide are gonna commit homicide. I'm actually the best person that a pharmaceutical company could use in terms of defending themselves, in the sense that if I interview a person who's been on a drug and has gone on commit homicide or whatever, believing that the drugs can cause this. If I say no, the drug hasn't caused it in this case, I'm going to be more credible than an expert who says, Oh no, these drugs can't cause a problem, because juries, faced with cases like this, have said, well, we're not going to believe the experts. We're not going to believe the company. We're not going to believe the published article. Published articles. It's very, very clear. I mean, juries of lay people have actually concluded, it's very, very clear that the drugs can cause the problem. Jury judges and prosecutors have quietly agreed with the defense that, yes, the only way to explain this man killing his wife was the influence of the drug he was on. Okay? Now, in terms of all of the mass homicides and things like that, where people have claimed the drugs have been involved, we have a big problem, which is the person who's shot. Everyone is usually dead as well. One case where this hasn't happened has been James Holmes, the Batman. Rises the

Nick Jikomesin the movie theater. Nice. Rises

David Healythe the Aurora, Colorado. Shooting, yeah. Holmes was a quiet, shy university student who was put on an SSRI by the the I forget the name of the university he was in, but by one of the doctors in the university he becomes. Is disinhibited and much less shy, and begins to keep a diary and gives a great description of the effects of SS rise on him. He's becoming manic and disinhibited. And he buys motorbike. He buys guns. He goes to shooting range and starts shooting. Never had done any of this before. Basically, his whole personality changes, yeah, yeah. And he starts thinking and talking about plans to shoot a bunch of people. He goes on to his doctor, who increases the dose of the pills, who he says to her, Look, you know, if you knew the thoughts going through my mind, you'd lock me up. And she looks at him and says, Well, you're responsible for what you do. And she doesn't think the drug could be causing the problem, right? Okay, so Holmes goes into the movie theater and shoots there 12 people and shoots and injures 72 and

Nick Jikomeswas this, was he disgruntled about something, or is this just sort of like spontaneously, he just has the notion in his mind that he's going to commit violence for no apparent

David Healyreason? No, he there's a little trend in his thinking. He's a very introverted, shy kind of character who is slightly misanthropic. He's nice, enthusiastic about other people. Okay, so maybe

Nick Jikomeshe wasn't having social success, and he developed a myth misanthropic viewpoint.

David HealyWell, not gross misanthrope. It was just, you know, the kind of thing where, I mean, some people love other people, others just, you know, wary about other people, yeah, not hugely enthusiastic about them. There was nothing particularly pathological here. But anyway, there's a few interesting angles to this. The defense team got in touch with me and said, Look, you know, we'd like you to come and look at the case. And I, from what they were saying, I wasn't hugely convinced that there was anything here to look at. It was only when I ended up in jail talking to him that I became convinced that, yes, absolutely, this drug had caused him to do what he did. He he was off the drug. This time he had been in jail for a while. At some point, while he was in jail, they put him back on an SSRI, and he became suicidal and tried to kill himself in jail, I ended up interviewing both his parents afterwards, who didn't know he was on an SSRI and might have had anything to do with his case. After all, this had happened, both of his parents, you know, at one point or another, got treated with an SSRI by their doctor, and both had reactions like his. They really not that they wanted to kill people, but they had clear personality reactions to the SSRIs that were consistent with the kinds of things that happened to him. Why? So, in the case, my hunch is that the public defender, he had, you know, they're not particularly in the business of winning a high profile case. They just want to make sure he isn't executed. He was in a state where you could have been executed. So it's going to be a win for them, if they could just get this past the jury so that he got jailed for something like 300,000 years or whatever it is, actually executed, okay, and in the end, they didn't use my testimony or the report that I'd done on them, saying, Look, this man was not guilty. Okay, part of the problem here is that, you know, you gotta try and persuade a jury tell a man who has killed 12 other people and seriously injured 72 others, walk out of jail, walk out of the court a free man. You know that's not something a jury going to be able to do in a hurry. You've got to persuade the jury that FDA knew these drugs could do it. You've got to persuade the jury that Pfizer knew that this drug, Zoloft, could do it because they'd given it to healthy volunteers 10 years before the drug came in the market for people who are depressed and shown the same things happening in healthy volunteers. And written at the bottom, our drug can cause this. So you know. And you've got all these articles in the New England Journal of Medicine and JAMA, which say, this drugs works. This drug works wonderfully well and is free of problems. Can you persuade a jury to tear up their view of the universe, anything that they've trusted up to this to destroy the Bible? You're not going to be able to do that in a hurry, particularly if you're a public defender, right? So my punch is that they came to an agreement with. The legal team for a fighter on the other side, we would ensure this guy doesn't get executed. Wow. So I can tell you about that. I mean, with all the other guys who are dead, we really can't know for sure. You can. You may know that they're on a drug. You may know that they're on a drug that can but okay, but we can get to interview the person. Yeah,

Nick Jikomesyou we've got this one case where the shooter survives. You personally were involved, and you sort of saw the whole thing from the inside out, and that's what you just told us. We've got all these other cases where we can't do that because the shooter was killed. But you know, if we start to think more generally about how common things like suicide and suicidal ideation are with SSRIs, can you give us just sort of the basic lay of the land? There is this a very common side effect?

David HealyYeah, in the healthy volunteer trial that we did, that I did, one in 10 of the volunteers became suicidal on an SSRI.

Nick JikomesI mean, that's a big effect. One in 10 becomes suicidal, and these are otherwise healthy people

David Healynow, yes, now, a lot of people, when this happens, have the wit to stop. And the curious thing about it all is that you've got some antihistamines which available over the counter, which are potent SSRIs and can cause you to become agitated and have withdrawal effects, and all the problems SSRIs can cause, really,

Nick Jikomesyes, like, like, what? Like, Zyrtec and

David Healychlorophenoramine, for instance, I'm not sure. What do the trade name in the United States, diphenhydramine, Benadryl, yeah, yeah, yeah. So in, I mean, what happens when it's over the counter? If you go and get this over the counter, I mean, you're not getting it as an SSI or as an antidepressant, but if you get this drug and take it and it doesn't suit you, what do you do? You stop it. You're not inhibited by a doctor who keeps saying, Oh, no, you need to keep taking it for six weeks before we stop it, you know, right? So part of the problem isn't just the drug, it's the interact, the fact that you can only get it through your doctor, and he's been educated by the nuclear journal medicine, goes certain fraudulent articles to think that there are no problems with these things, and if you're complaining, you're just an anecdote, and this is all in your mind. In fact, you know, more seriously, torture and so

Nick Jikomeswell. I mean, I want to thank you for your time, because we've already talked a little bit longer than our schedule. But you know, this is obviously a big topic. This touches a lot of people, because these things are prescribed to so many people that you know, if you're not on one or habit on one yourself, you certainly know people who have been any final thoughts or major takeaways you want to take? Do you want to leave people with about this general subject of SSRIs and the whole enterprise of of psychiatric medicine today?

David HealyYeah. First of all, it's there are a lot of people who can be helped by SSRIs, and as I've indicated, I don't not prescribe them. The issue isn't so much the pills, per se. It's the way doctors have been manipulated and educated into using these pills, which is a harmful thing. Our medical journals have failed us. It's it's not so much the pills that are failing us. It's much more a case of the medical system, the doctors, our journals and things like the the professionalism that just isn't there, the willingness to stand up on behalf of the people that were treating, the people that were making money out of you know, were not doing it. We're not showing backbone. So the issue it's a mistake. You're not going to solve the problem by just trying to get rid of pills. You've got to call on doctors to really step up to the place. That's the key thing. And it's not just the SSRI group drugs. It's all drugs. It's the statins, it's antibiotics, it's every drug we use is, well, almost all the drugs you use are actually affected in much the same ways. It's the same, yeah, ghost writing. It's the same hiding of the data and a bunch of problems that you're told, Well, no, this is, this is all in your mind.

Nick JikomesIs it? For those of us that look at the literature, directly or indirectly, we're reading clinical trials or reading about clinical trials. In your view, in terms of ghost writing, industry bias and things like that, when we read papers about these drug trials, should we assume they're innocent until proven guilty, or guilty until proven innocent?

David HealyYeah, I think you've got to recognize the first of all, companies aren't doing trials to inform clinical practice. That's. Yes, do the first thing. Secondly, they are going to have massaged the article and the data, and just because it appears in a really good journal, you can't necessarily credit the fact that it is going to be honest and these things, the better the journal it's in, the more useful for industry in terms of being able to market the drugs, because it's in a good journal, and it gets built into, it gets built into the standards of care, which shape what doctors do, and the figure, if they aren't keeping to the standards of care, they're at legal risk themselves, so of course, they're not going to keep the standards of care. If they agree with you that the drugs causing problem. They're going to lose their job if they agree with you, it's much easier. It's better for the organization they work in. It's more legally defensible to stick with what the standard of care says. So, yeah, so it's a tricky situation we've got, and it's one that badly needs reform. Whether we're going to get the reform or not, I'm not sure.

Nick JikomesWell, David, thank you very much for your time. This was fascinating and, you know, obviously disturbing in many ways, but this is important information for people, and I really, really appreciate it.

David HealyOkay, it was good to chat next. Thanks. You.

Nick Jikomes: If you like to read like I do, then you should check out the read wise app. It's totally free to download, and if you go through the link in the episode description or on my support page, you can get a free 60 day trial for zero cost. Readwise is a really cool app that allows you to import digital highlights from over 30 different platforms, such as Kindle, iBooks, PDFs and more. It makes it really easy for you to review and find and share excerpts and quotes from whatever it is that you're reading, whether it's PDFs of scientific papers or books that you're reading on your Kindle. And you can even save and use highlights from physical books. I read a lot of physical books before bed, for example, or when I'm traveling. And the read wise app actually integrates with the camera on your phone so that you can take a photo of a page that you're reading, highlight a specific chunk of text from that page and export it to the app so that you can reference it or find it or share it later. They even allow you to export really cool looking graphics of some of the highlights that you have in the books or the papers you're reading, so that you can share them in an engaging way. So check out the readwise app today. If you are a reader and you like to reference and organize what you read, go through the link in the episode description, or on my support page or in my free weekly newsletter@mindandmatter.substack.com and try the readwise app. 60 days free today. Transcribed by https//otter.ai

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Seed Oils, Omega-3s & Lessons From 93 Years of Life | Artemis Simopoulos | 313

    Nov 17, 20261 hr 35 minAudio

    Send us Fan Mail At 93, Artemis Simopoulos explains why oils once used in paint now dominate the food supply, how a high omega-6 intake slows the making of EPA and DHA, and why cholesterol-lowering corn oil did not...

    Credit the people on this episode

  2. Tendons, Collagen, mTOR & Exercise Adaptation | Keith Baar | Episode 312

    Nov 10, 20262 hrAudio

    Send us Fan Mail Keith Baar explains why tendons stop adapting after 10 minutes of loading, why long low-load holds beat fast reps for connective tissue, and how vitamin C, collagen, caffeine and mTOR shape training....

    Credit the people on this episode

  3. GDF15, Morning Sickness & Mitochondrial Stress | Stephen O'Rahilly | Episode 311

    Nov 3, 20261 hr 29 minAudio

    Send us Fan Mail Dr. Stephen O'Rahilly explains GDF15, a stress hormone that makes us feel sick and eat less, and why morning sickness, and its severe form hyperemesis gravidarum (HG), comes from GDF15 made by the...

    Credit the people on this episode

  4. Psilocybin vs. SSRIs for Depression, Emotional Blunting & How Psychedelics Work | Robin Carhart-Harris | 310

    Oct 26, 20261 hr 56 minAudio

    Send us Fan Mail Robin Carhart-Harris explains why his trial of psilocybin therapy vs. the SSRI escitalopram for depression missed one primary measure but favored psilocybin on almost everything else, and why SSRIs can...

    Credit the people on this episode

  5. This Animal Survives 18 Minutes Without Oxygen | Gary Lewin | 309

    Oct 12, 20261 hr 40 minAudio

    Send us Fan Mail Nick talks with Prof. Gary Lewin (Max Delbrück Center, Berlin) about naked mole-rats, which in lab tests survived 18 minutes in pure nitrogen by shutting down brain activity, keeping the heart beating,...

    Credit the people on this episode